Spots Global Cancer Trial Database for cardiac toxicity
Every month we try and update this database with for cardiac toxicity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum | NCT01719562 | Cardiac Toxicit... Malignant Neopl... Breast Cancer | Magnetic resona... Physical Activi... Healthy Living Cardiopulmonary... Questionnaire A... | 18 Years - 85 Years | Wake Forest University Health Sciences | |
| Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart | NCT02881203 | Breast Cancer | Breathe Well RPM | 18 Years - | University of Sydney | |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | NCT00039481 | Cardiac Toxicit... Unspecified Chi... | oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart | NCT02881203 | Breast Cancer | Breathe Well RPM | 18 Years - | University of Sydney | |
| Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE) | NCT05454553 | Breast Cancer | myocardial perf... | 18 Years - | Institut de cancérologie Strasbourg Europe | |
| MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum | NCT01719562 | Cardiac Toxicit... Malignant Neopl... Breast Cancer | Magnetic resona... Physical Activi... Healthy Living Cardiopulmonary... Questionnaire A... | 18 Years - 85 Years | Wake Forest University Health Sciences | |
| CADY Study ICORG 08-01 | NCT00968682 | Breast Cancer Cardiac Toxicit... | trastuzumab laboratory biom... assessment of t... | 18 Years - | Cancer Trials Ireland | |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | NCT00003937 | Cardiac Toxicit... Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide methotrexate conventional su... | - 30 Years | Children's Oncology Group | |
| COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) | NCT05258448 | Cardiac Toxicit... Lung Cancer Sta... Lung Cancer Sta... Radiation Toxic... Cardiac Disease | Chemoradiothera... | 18 Years - | Odense University Hospital | |
| Prospective Observation of Cardiac Safety With Proteasome Inhibition | NCT02178579 | Heart Failure Multiple Myelom... | 18 Years - | Vanderbilt University Medical Center | ||
| Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma | NCT01230983 | Cardiac Toxicit... Leukemia Lymphoma | asparaginase cytarabine dexrazoxane hyd... doxorubicin hyd... leucovorin calc... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart | NCT02052102 | Breast Cancer Adverse Effect ... | Radiation thera... | 18 Years - 70 Years | AHS Cancer Control Alberta | |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | NCT00016276 | Cardiac Toxicit... Inflammatory Br... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... | dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... paclitaxel trastuzumab therapeutic con... radiation thera... tamoxifen citra... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients | NCT04962425 | Cardiac Toxicit... Antitumor Drugs Breast Cancer | Trastuzumab | 18 Years - | Peking University Third Hospital | |
| The STOP-MED CTRCD Trial | NCT06183437 | Heart Failure Cardiotoxicity Cardiac Toxicit... Antineoplastics... Cancer | Stopping Heart ... | 18 Years - | University Health Network, Toronto | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Exercise Response After Revalidation in Cancer Patients | NCT04461392 | Oncology Cardiac Toxicit... | Cardiorespirato... | 18 Years - 90 Years | Universitair Ziekenhuis Brussel | |
| Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) | NCT01032278 | Cardiac Toxicit... Unspecified Adu... | Laboratory Biom... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | NCT00728429 | Cardiac Toxicit... Chemotherapeuti... Unspecified Adu... | exercise interv... | 18 Years - 80 Years | Wake Forest University Health Sciences | |
| Prospective Observation of Cardiac Safety With Proteasome Inhibition | NCT02178579 | Heart Failure Multiple Myelom... | 18 Years - | Vanderbilt University Medical Center | ||
| Association Between Telomere Length and Cardiac Dysfunction | NCT04409379 | Cardiac Toxicit... Acute Leukemia Childhood Cance... | Relative telome... | 1 Year - 16 Years | Air Force Military Medical University, China | |
| Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | NCT00728429 | Cardiac Toxicit... Chemotherapeuti... Unspecified Adu... | exercise interv... | 18 Years - 80 Years | Wake Forest University Health Sciences | |
| Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab | NCT01009918 | Breast Cancer Cardiac Toxicit... | Coreg CR® lisinopril placebo | 18 Years - | University of South Florida | |
| The STOP-MED CTRCD Trial | NCT06183437 | Heart Failure Cardiotoxicity Cardiac Toxicit... Antineoplastics... Cancer | Stopping Heart ... | 18 Years - | University Health Network, Toronto | |
| Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery | NCT00436566 | Breast Cancer Cardiac Toxicit... | trastuzumab cyclophosphamid... doxorubicin hyd... lapatinib ditos... paclitaxel gene expression... reverse transcr... fluorophotometr... laboratory biom... mass spectromet... adjuvant therap... quality-of-life... | 18 Years - 120 Years | Mayo Clinic | |
| SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial | NCT00002900 | Breast Cancer Cardiac Toxicit... | management of t... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | NCT00003070 | Cardiac Toxicit... Unspecified Chi... | enalapril malea... quality-of-life... | 8 Years - | Children's Oncology Group | |
| Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy | NCT00563407 | Genetic Markers Cardiac Toxicit... Breast and Skin... | 18 Years - | AHS Cancer Control Alberta | ||
| Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | NCT00005578 | Cardiac Toxicit... Lymphoma | bleomycin sulfa... filgrastim cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide prednisone vincristine sul... radiation thera... | - 21 Years | Children's Oncology Group | |
| Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial | NCT05403736 | Cancer | Cardiac Aggress... | 18 Years - | Cedars-Sinai Medical Center | |
| Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients | NCT04962425 | Cardiac Toxicit... Antitumor Drugs Breast Cancer | Trastuzumab | 18 Years - | Peking University Third Hospital | |
| The CAROLE (CArdiac Related Oncologic Late Effects) Study | NCT03235427 | Coronary Artery... Cardiac Disease Cardiac Toxicit... Radiation Radiation Thera... Atherosclerotic... Cardiotoxicity Breast Cancer Lung Cancer Lymphoma Cancer Carcinoma, Intr... | 26 Years - 78 Years | Northwell Health | ||
| Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | NCT00003070 | Cardiac Toxicit... Unspecified Chi... | enalapril malea... quality-of-life... | 8 Years - | Children's Oncology Group | |
| Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. | NCT06277388 | Non-small Cell ... Cardiac Toxicit... | Impedance cardi... | 18 Years - 75 Years | Sun Yat-sen University | |
| Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG | NCT04892667 | Lymphoma, Non-H... Lymphoma, Hodgk... | intervention | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Exercise Response After Revalidation in Cancer Patients | NCT04461392 | Oncology Cardiac Toxicit... | Cardiorespirato... | 18 Years - 90 Years | Universitair Ziekenhuis Brussel | |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | NCT00039481 | Cardiac Toxicit... Unspecified Chi... | oblimersen sodi... dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... filgrastim laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | NCT00002827 | Cardiac Toxicit... Lymphoma | bleomycin sulfa... filgrastim dexrazoxane hyd... doxorubicin hyd... etoposide vincristine sul... low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| Association Between Telomere Length and Cardiac Dysfunction | NCT04409379 | Cardiac Toxicit... Acute Leukemia Childhood Cance... | Relative telome... | 1 Year - 16 Years | Air Force Military Medical University, China | |
| Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial | NCT05403736 | Cancer | Cardiac Aggress... | 18 Years - | Cedars-Sinai Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
